mRNA-1273-话题@MedSci

#mRNA-1273#

30篇内容 | 2630人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1822622, encodeId=16841822622da, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=Moderna递交Omicron特异性mRNA疫苗mRNA-1273.222紧急使用授权申请, objectType=article, longId=736906, objectId=625fe3690684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=625fe3690684, replyNumber=0, likeNumber=116, createdTime=2023-06-01, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=625fe3690684, moduleTitle=Moderna递交Omicron特异性mRNA疫苗mRNA-1273.222紧急使用授权申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=625fe3690684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822620, encodeId=8be518226206c, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=莫德纳第二代mRNA新冠疫苗mRNA-1273.214，对BA.4/5效果良好，中和抗体平均滴度达到941, objectType=article, longId=732213, objectId=e35fe322138b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e35fe322138b, replyNumber=0, likeNumber=90, createdTime=2023-03-31, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e35fe322138b, moduleTitle=莫德纳第二代mRNA新冠疫苗mRNA-1273.214，对BA.4/5效果良好，中和抗体平均滴度达到941, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e35fe322138b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822614, encodeId=00b518226146e, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：mRNA疫苗谁更强——mRNA-1273疫苗效果优于BNT162b2疫苗, objectType=article, longId=221455, objectId=364e221455fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=364e221455fb, replyNumber=0, likeNumber=104, createdTime=2022-03-15, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=364e221455fb, moduleTitle=NEJM：mRNA疫苗谁更强——mRNA-1273疫苗效果优于BNT162b2疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=364e221455fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822621, encodeId=40121822621fe, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=莫德纳针对BA.4/5变异株的新冠疫苗加强针mRNA-1273.222预计今年秋季推出, objectType=article, longId=733008, objectId=49d8e330086f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49d8e330086f, replyNumber=0, likeNumber=79, createdTime=2022-11-19, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49d8e330086f, moduleTitle=莫德纳针对BA.4/5变异株的新冠疫苗加强针mRNA-1273.222预计今年秋季推出, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49d8e330086f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822611, encodeId=2207182261162, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：BNT162b2和mRNA-1273疫苗可有效预防医护人群出现症状性新冠肺炎感染, objectType=article, longId=217810, objectId=f5e221e8101f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5e221e8101f, replyNumber=0, likeNumber=0, createdTime=2022-06-24, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5e221e8101f, moduleTitle=NEJM：BNT162b2和mRNA-1273疫苗可有效预防医护人群出现症状性新冠肺炎感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5e221e8101f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822617, encodeId=7b40182261eb6, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=BMJ：mRNA-1273接种后中青年，BNT162b2接种后女性心肌炎心包炎风险增加, objectType=article, longId=292418, objectId=2f6a292418fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f6a292418fe, replyNumber=0, likeNumber=70, createdTime=2022-10-01, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f6a292418fe, moduleTitle=BMJ：mRNA-1273接种后中青年，BNT162b2接种后女性心肌炎心包炎风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f6a292418fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822612, encodeId=b95a182261211, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=AJKD：血液透析患者对mRNA-1273和BNT162b2 SARS-CoV-2疫苗的体液和细胞反应, objectType=article, longId=218314, objectId=6a932183142b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a932183142b, replyNumber=0, likeNumber=88, createdTime=2022-04-07, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a932183142b, moduleTitle=AJKD：血液透析患者对mRNA-1273和BNT162b2 SARS-CoV-2疫苗的体液和细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a932183142b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822618, encodeId=561c18226181c, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：头对头研究证实mRNA-1273疫苗的有效性优于BNT162b2疫苗, objectType=article, longId=294144, objectId=f46229414423, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f46229414423, replyNumber=0, likeNumber=86, createdTime=2022-11-06, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f46229414423, moduleTitle=NEJM：头对头研究证实mRNA-1273疫苗的有效性优于BNT162b2疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f46229414423)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822619, encodeId=b28d1822619de, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=Nat Med：mRNA-1273疫苗对SARS-CoV-2奥密克戎和Delta变异株的有效性分析, objectType=article, longId=299429, objectId=e02a299429ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e02a299429ef, replyNumber=0, likeNumber=83, createdTime=2022-08-30, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e02a299429ef, moduleTitle=Nat Med：mRNA-1273疫苗对SARS-CoV-2奥密克戎和Delta变异株的有效性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e02a299429ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822615, encodeId=13151822615b0, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：青少年接种SARS-CoV-2 mRNA-1273疫苗的效果, objectType=article, longId=221796, objectId=eae1221e965c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eae1221e965c, replyNumber=0, likeNumber=74, createdTime=2021-12-20, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eae1221e965c, moduleTitle=NEJM：青少年接种SARS-CoV-2 mRNA-1273疫苗的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eae1221e965c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822608, encodeId=5b3b1822608ae, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=JAMA：肾移植受者应接种三剂mRNA-1273 SARS-CoV-2疫苗, objectType=article, longId=214819, objectId=6079214819ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6079214819ed, replyNumber=0, likeNumber=83, createdTime=2022-01-30, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6079214819ed, moduleTitle=JAMA：肾移植受者应接种三剂mRNA-1273 SARS-CoV-2疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6079214819ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822616, encodeId=91ff1822616d6, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：BNT162b2和mRNA-1273疫苗在一线医护人群中的效果研究, objectType=article, longId=292176, objectId=47662921e60c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47662921e60c, replyNumber=0, likeNumber=76, createdTime=2022-11-16, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47662921e60c, moduleTitle=NEJM：BNT162b2和mRNA-1273疫苗在一线医护人群中的效果研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47662921e60c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822610, encodeId=dc14182261015, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：mRNA-1273疫苗接种后5个月防护效果仍高达93%, objectType=article, longId=217811, objectId=e8af21e8112f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8af21e8112f, replyNumber=0, likeNumber=62, createdTime=2022-08-08, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8af21e8112f, moduleTitle=NEJM：mRNA-1273疫苗接种后5个月防护效果仍高达93%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8af21e8112f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822613, encodeId=c6f5182261346, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：BNT162b2， mRNA-1273和 Ad26.COV2.S疫苗真实世界研究结果喜人, objectType=article, longId=218836, objectId=0724218836a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0724218836a1, replyNumber=0, likeNumber=83, createdTime=2022-08-08, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0724218836a1, moduleTitle=NEJM：BNT162b2， mRNA-1273和 Ad26.COV2.S疫苗真实世界研究结果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0724218836a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822607, encodeId=227e182260e38, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：BNT162b2和mRNA-1273疫苗预防新冠肺炎真实世界研究数据喜人, objectType=article, longId=214785, objectId=6ce6214e8567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ce6214e8567, replyNumber=0, likeNumber=84, createdTime=2021-09-03, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ce6214e8567, moduleTitle=NEJM：BNT162b2和mRNA-1273疫苗预防新冠肺炎真实世界研究数据喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ce6214e8567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822609, encodeId=4b6418226093e, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：mRNA-1273疫苗在12-17岁青少年人群中效果评估, objectType=article, longId=215729, objectId=44a8215e291f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44a8215e291f, replyNumber=0, likeNumber=65, createdTime=2021-10-03, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44a8215e291f, moduleTitle=NEJM：mRNA-1273疫苗在12-17岁青少年人群中效果评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44a8215e291f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822605, encodeId=54ca18226050d, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=低于辉瑞疫苗！美国第2款新冠候选疫苗mRNA-1273疗效公布, objectType=article, longId=205349, objectId=8e42205349da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e42205349da, replyNumber=0, likeNumber=64, createdTime=2021-12-06, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e42205349da, moduleTitle=低于辉瑞疫苗！美国第2款新冠候选疫苗mRNA-1273疗效公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e42205349da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822598, encodeId=5b9e1822598f3, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：COVID-19候选疫苗mRNA-1273的临床前研究，效果明显！, objectType=article, longId=198318, objectId=b1ae19831868, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1ae19831868, replyNumber=0, likeNumber=75, createdTime=2021-05-02, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1ae19831868, moduleTitle=NEJM：COVID-19候选疫苗mRNA-1273的临床前研究，效果明显！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1ae19831868)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822600, encodeId=ead618226006b, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=NEJM：mRNA-1273新冠肺炎疫苗对非人灵长类动物的保护作用, objectType=article, longId=202161, objectId=43e020216180, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43e020216180, replyNumber=0, likeNumber=94, createdTime=2021-08-01, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43e020216180, moduleTitle=NEJM：mRNA-1273新冠肺炎疫苗对非人灵长类动物的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43e020216180)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822597, encodeId=985c182259edc, content=<a href='/topic/show?id=a410122250d' target=_blank style='color:#2F92EE;'>#mRNA-1273#</a>, objectTitle=COVID-19候选疫苗mRNA-1273的III临床试验：规模将继续扩大, objectType=article, longId=198171, objectId=c8e91981e1ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8e91981e1ab, replyNumber=0, likeNumber=69, createdTime=2020-09-28, rootId=0, userName=liao1619, userId=e03212, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8e91981e1ab, moduleTitle=COVID-19候选疫苗mRNA-1273的III临床试验：规模将继续扩大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8e91981e1ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

mRNA-1273

2020-05-29

爆笑小医 (审核中...)

前往app查看评论内容

#mRNA-1273#

Moderna递交Omicron特异性mRNA疫苗mRNA-1273.222紧急使用授权申请

2023-06-01

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

莫德纳第二代mRNA新冠疫苗mRNA-1273.214，对BA.4/5效果良好，中和抗体平均滴度达到941

2023-03-31

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：mRNA疫苗谁更强——mRNA-1273疫苗效果优于BNT162b2疫苗

2022-03-15

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

莫德纳针对BA.4/5变异株的新冠疫苗加强针mRNA-1273.222预计今年秋季推出

2022-11-19

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：BNT162b2和mRNA-1273疫苗可有效预防医护人群出现症状性新冠肺炎感染

2022-06-24

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

BMJ：mRNA-1273接种后中青年，BNT162b2接种后女性心肌炎心包炎风险增加

2022-10-01

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

AJKD：血液透析患者对mRNA-1273和BNT162b2 SARS-CoV-2疫苗的体液和细胞反应

2022-04-07

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：头对头研究证实mRNA-1273疫苗的有效性优于BNT162b2疫苗

2022-11-06

docwu2019 (审核中...)

前往app查看评论内容

#mRNA-1273#

Nat Med：mRNA-1273疫苗对SARS-CoV-2奥密克戎和Delta变异株的有效性分析

2022-08-30

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：青少年接种SARS-CoV-2 mRNA-1273疫苗的效果

2021-12-20

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

JAMA：肾移植受者应接种三剂mRNA-1273 SARS-CoV-2疫苗

2022-01-30

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：BNT162b2和mRNA-1273疫苗在一线医护人群中的效果研究

2022-11-16

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：mRNA-1273疫苗接种后5个月防护效果仍高达93%

2022-08-08

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：BNT162b2， mRNA-1273和 Ad26.COV2.S疫苗真实世界研究结果喜人

2022-08-08

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：BNT162b2和mRNA-1273疫苗预防新冠肺炎真实世界研究数据喜人

2021-09-03

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：mRNA-1273疫苗在12-17岁青少年人群中效果评估

2021-10-03

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

低于辉瑞疫苗！美国第2款新冠候选疫苗mRNA-1273疗效公布

2021-12-06

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：COVID-19候选疫苗mRNA-1273的临床前研究，效果明显！

2021-05-02

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

NEJM：mRNA-1273新冠肺炎疫苗对非人灵长类动物的保护作用

2021-08-01

liao1619 (审核中...)

前往app查看评论内容

#mRNA-1273#

COVID-19候选疫苗mRNA-1273的III临床试验：规模将继续扩大

2020-09-28

科室
- - 订阅+
  - 更多科室
工具
服务